Journal of Clinical Psychopharmacology

Papers
(The median citation count of Journal of Clinical Psychopharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Trazodone and Mianserin for Delirium47
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting44
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia34
Question33
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment27
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient27
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report22
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease20
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients20
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman19
Author Index 202217
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?16
Postinjection Syndrome After Paliperidone?14
Possibly Misleading Pharmaceutical Advertising On TV14
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms14
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition13
Dysphagia to Liquids Only Associated With Olanzapine13
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases12
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation12
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates12
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration12
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia12
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine11
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use11
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole11
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux11
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings11
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation11
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?10
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus10
Thoughts on the Value of Case Series in the Literature10
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice10
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy10
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia10
Neuroleptic Malignant Syndrome Associated With Lurasidone9
Drug-Associated Liver Injury Related to Antipsychotics9
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy9
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin9
SALUTE TO OUR REVIEWERS9
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior9
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders8
Clozapine Once-Daily Versus Divided Dosing Regimen8
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders8
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum8
Factors Associated With Poor Response to Clozapine in Schizophrenia8
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment8
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio8
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report8
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine7
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine7
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets7
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel7
Aripiprazole as First-Line Therapy for Late-Life Depression7
Untreated Mental Illness Has Created a National Tragedy7
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression7
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder7
Journal of Clinical Psychopharmacology Updates7
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer6
Mania Associated With Cariprazine6
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE1046
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature6
Use of Clozapine in Pregnancy6
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist6
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior6
Question6
Clozapine- and Lithium-Associated Myoclonus6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials6
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review6
Plasma Clozapine in Treatment Refractory Schizophrenia6
A Manic Episode With Psychotic Features Associated With Levetiracetam6
Clozapine-Associated Agranulocytosis6
Clozapine Use in Down Syndrome5
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia5
Incorporating Real-World Treatment Data Into Clozapine's Product Label5
Author Index 20245
Alpha Lipoic Acid for Schizophrenia5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?5
Dysphagia From Long-Term Olanzapine Use5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants5
Resolution of Catatonia With Cariprazine—A Case Report5
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan5
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder5
Hematological and Other Cancers in People Using Clozapine5
Subject Index 20225
A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders5
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder5
Pharmacokinetics of Ketamine Transfer Into Human Milk5
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient5
Mania-Like Reaction Secondary to Sodium Oxybate5
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD5
Clozapine Associated Periorbital Edema in First Episode Psychosis5
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms4
Response to Letter to the Editors From Prof D. Taylor4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia4
You Shall Not Turn a Blind Eye to Intraocular Pressure4
Methamphetamine-Associated Hyperammonemic Encephalopathy4
Valproic Acid–Associated Hyperammonemia4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)4
Neurotoxicity Related to Multidrug Association: A Case Report4
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users4
Article Selected to Receive the Mitchell B. Balter Award for 20224
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine4
Exploring the Addictive Potential of Tranylcypromine4
Methylphenidate-Associated Syncope4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination4
Are the Same Medications that Are Used in the Acute Treatment of Depression the Most Suitable for Preventing Relapse?4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report4
Characterization of Extended-Release Lorazepam4
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth4
Detecting Anxious Distress, an Important Mood Specifier4
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning4
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma4
Can Quetiapine Prolong the Antidepressant Effect of Ketamine?4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use4
Esketamine for Unipolar Major Depression With Psychotic Features4
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder4
The Need for Non-profit Psychiatric Drug Discovery and Development4
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients4
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome3
Evaluating the Quality of Randomized Controlled Trials3
Ketamine and Esketamine for Depression in Daily Practice3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism3
How Does Drug Company Marketing Affect Physician Prescribing?3
Journal of Clinical Psychopharmacology Updates3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit3
A First Trimester Exposure to Ketamine and Esketamine for Depression3
Toxidrome of an Easily Obtainable Nootropic3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient3
Tardive Dyskinesia Suppressed With Ginkgo Biloba3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion3
Severe Alprazolam Withdrawal With Delirium and Psychosis3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination3
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder: Erratum3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants3
Response to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine3
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants3
Assessing Adherence to Clozapine3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia3
Panic Disorder Seeks More Specific Drugs for Treatment3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia3
Venlafaxine-Associated Rhabdomyolysis3
Journal of Clinical Psychopharmacology Updates3
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder2
Citalopram Associated with the Development of Tinnitus in an Adolescent Girl2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”2
Advancing the Development of New Medications to Treat Psychiatric Illness2
Appendicitis Associated With Clozapine2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use2
Antipsychotic-Related Fatal Poisoning, England and Wales, 1993–20192
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder2
Late-Onset Neutropenia With Clozapine Associated With Lithium Carbonate–Related Hyperthyroidism2
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital2
Question2
Catatonia Associated With Valbenazine Treatment2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania2
Hypotension and Peripheral Edema With Moclobemide2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents2
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics2
Risk of Neutropenia Associated With Duloxetine2
Question2
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series2
Citalopram-Associated Hyponatremia Presenting as Distal Extremity Numbness2
Prescription Stimulants and the Risk of Psychosis2
Further Studies of Effects of Finasteride on Mood and Suicidal Risk2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum2
Ketamine's Altered States Meta-Analysis2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder2
Monoamine Oxidase Inhibitors for Trichotillomania2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals2
Endoxifen Approval for Bipolar Disorder in India2
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression2
Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association2
Gastrointestinal Hemorrhage After Antidepressant Drug Use2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-192
Semaglutide-Mediated Lithium Toxicity2
Modafinil Use in an Adolescent With Major Depressive Disorder2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress2
Prebiotic Treatment in People With Schizophrenia2
Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia2
Question2
Treatment History Characteristics Associated With Use of Isocarboxazid2
Pleural Effusion Associated With Divalproex Sodium2
Question2
Antidepressant Poisoning Trends in Pediatric Intensive Care2
Clinician Reasons for Stopping Clozapine2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India2
Depression and Catatonia Associated With Lansoprazole in an Adolescent With Phelan-McDermid Syndrome2
Catatonia and Delirium2
Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice2
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression2
Sertraline-Associated Burning Mouth Syndrome2
Does Bupropion Increase Anxiety?2
α-PVP Associated Psychosis2
Statistical Versus Clinical Significance2
The Rise and Fall of the Age of Psychopharmacology2
Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics2
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine2
Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression2
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes2
Painful Ejaculation Associated With Atomoxetine and Bupropion2
Use of Blonanserin Transdermal Patch in Home Treatment of Schizophrenia2
Blepharospasm Arising From Escitalopram Use2
The Treatments of Depressive Disorders/Cognitive Dysregulation With Dietary Phytosterols1
Methylphenidate-Associated Ecchymosis in a Young Patient With Poststroke Attention Deficit1
Psychopharmacology1
Depression in Persons With Epilepsy1
A Case Report and Mini Review on Clozapine Treatment During Chemotherapy1
Concomitant Use of Dextromethorphan/Bupropion and Escitalopram Associated With Serotonin Toxicity in an Older Adult: A Case Report1
0.066447019577026